Axsome Therapeutics said on Tuesday its experimental drug to treat attention deficit hyperactivity disorder (ADHD) met its main goal in a late-stage study. The drug, solriamfetol, helped ease symptoms ...
Axsome Therapeutics' experimental drug to treat attention deficit hyperactivity disorder (ADHD) helped improve symptoms of the developmental disorder in adults, it said on Tuesday, meeting the main ...
Abruptly discontinuing your ADHD medication may cause rebound symptoms. Learn more about the rebound effect and how your ...
Deciding whether to pursue medication for your child's ADHD is a personal decision with many factors to consider.
The preion rate for ADHD medications, such as Adderall and Ritalin, among women aged 35 to 64 has surged dramatically in recent years. By the end of 2022, 1.7 million women in this age group were ...
Axsome Therapeutics (AXSM) stock gains as solriamfetol, its experimental drug for ADHD succeeds in a Phase 3 trial. Read more ...
Taking a gamble by purchasing the rights to an underperforming narcolepsy drug may soon begin paying dividends for Axsome ...
A new study finds that nearly half of the most popular ADHD videos on TikTok share misleading claims that don't match ...
IT’S no secret the NHS is in crisis. A&E departments are overwhelmed, staff are at breaking point, patients are treated and ...
Everyday Health on MSN8d
ADHD Drugs Under Scrutiny by RFK Jr.'s Make America Healthy Again (MAHA) CommissionA Trump executive order forming the commission tasked them with assessing the ‘threat posed by’ ADHD meds. Learn how experts ...
Cleveland Police said the prescribed medication methylphenidate, a drug typically used to treat attention deficit ...
The 37-year-old Canadian musician, who shares three kids with Elon Musk, seemed to be grateful that she had not been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback